Atlas FDA

NeuroPace® RNS® System

FDA premarket approval P100026/S092 · decided 2023-02-10

Approval details

PMA number
P100026
Supplement
S092
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
NeuroPace® RNS® System
Generic name
Implanted brain stimulator for epilepsy
Applicant
NeuroPace, Inc.
Date received
2022-10-17
Decision date
2023-02-10
Days to decision
116 days
Decision code
APPR
Product code
PFN
Advisory committee
Neurology
Expedited review
No
Location
Mountain View, CA
Statement
Approval for a revised the RNS System Implanting and Programming Program Qualifications Questionnaire as follows:1) Provided a list of current diagnostic technologies utilized to identify the seizure onset;2) Clarified that qualified neurosurgeon(s) are ABNS board-certified or board-eligible and tracking toward certification, with experience in epilepsy surgery procedures and placement of intracranial electrodes;3) Specified that an established referral relationship is needed to ensure access to

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NEUROPACE BURR HOLE COVER (K141368)NeuroPace, Inc.2014-07-11
NEUROPACE BURR HOLE COVER MODEL 8110 (K123163)NeuroPace, Inc.2013-01-18